Important Safety Information:
CONTRAINDICATIONS: ELOCTATE is contraindicated in patients who have had life-threatening hypersensitivity reactions to ELOCTATE or its excipients.
WARNINGS AND PRECAUTIONS: Hypersensitivity reactions have been
reported with ELOCTATE. Allergic-type hypersensitivity reactions, including
anaphylaxis, have been reported with Factor VIII replacement products.
Bleed protection* for whatever moves them
INDICATION: ELOCTATE is a recombinant DNA derived, antihemophilic factor indicated in adults and children with Hemophilia A (congenital Factor VIII deficiency) for: on-demand treatment and control of bleeding episodes, perioperative management of bleeding, and routine prophylaxis to reduce the frequency of bleeding episodes. Limitation of Use
ELOCTATE is not indicated for the treatment of von Willebrand disease.